Suchergebnisse - "Itolizumab"

PubPharm (12)

1

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

2

An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes

enthalten in: Journal of clinical medicine | 2022

von Cabrera-Rode, E. | Cubas-Dueñas, I. | Rodríguez-Acosta, J. | +15

3

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

4

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

enthalten in: Immunity & ageing : I & A | 2020

von Saavedra, D. | Añé-Kourí, A. | Sánchez, N. | +14

5

Anti-CD6 mAbs for the treatment of psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Dogra, S. | D, S. | Rajagopalan, M.

6

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

enthalten in: Expert opinion on biological therapy | 2020

von Loganathan, S. | Athalye, S. | Joshi, S.

7

Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era

enthalten in: SN comprehensive clinical medicine | 2020

von Thangaraju, P. | Venkatesan, N. | Thangaraju, E. | +1

8

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

enthalten in: Gerontology | 2020

von Díaz, Y. | Ramos-Suzarte, M. | Martín, Y. | +17

9

Clinical and experimental evidence for targeting CD6 in immune-based disorders

enthalten in: Autoimmunity reviews | 2018

von Consuegra-Fernández, M. | Lin, F. | Fox, D. | +1

10

Itolizumab, a novel anti-CD6 monoclonal antibody : a safe and efficacious biologic agent for management of psoriasis

enthalten in: Expert opinion on biological therapy | 2017

von Dogra, S. | Uprety, S. | Suresh, S.